Capillary Leak Syndrome in Trauma. What is it and What are the Consequences?

Advances in Surgery

Volumn 46, Issue 1, 2012, Pages 237-253

  Stein, Deborah M ^a,b   Scalea, Thomas M ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b R ADAMS COWLEY SHOCK TRAUMA CENTER   (United States)

Author keywords

Capillary leak syndrome; Compartment syndrome; Systemic inflammation; Traumatic injury

Indexed keywords

CAPILLARY LEAK SYNDROME; FLUID THERAPY; HUMAN; INJURY; INTRAABDOMINAL HYPERTENSION; MULTIPLE TRAUMA; PATHOPHYSIOLOGY; RESUSCITATION; REVIEW;

CAPILLARY LEAK SYNDROME; FLUID THERAPY; HUMANS; INTRA-ABDOMINAL HYPERTENSION; MULTIPLE TRAUMA; RESUSCITATION; WOUNDS AND INJURIES;

EID: 84863431207     PISSN: 00653411     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yasu.2012.03.008     Document Type: Review

References (125)

1. Dutton R.P., Stansbury L.G., Leone S., et al. Trauma mortality in mature trauma systems: are we doing better? An analysis of trauma mortality patterns, 1997-2008. J Trauma 2010, 9(3):620-626.
2. Deitch E.A., Goodman E.R. Prevention of multiple organ failure. Surg Clin North Am 1999, 79(6):1471-1488.
3. Baue A.E. MOF/MODS, SIRS: an update. Shock 1996, 6:1-5.
4. Bochicchio G, Ilahi O, Bochicchio K, et al. Traumatic induced capillary leak syndrome is highly predictive of mortality [abstract 6]. In: Programs and abstracts of the 131st Annual Meeting of the American Surgical Association. Boca Raton (FL), April 14-16, 2011. p. 53.
5. Gosling P., Brudney S., McGrath L., et al. Mortality prediction at admission to intensive care: a comparison of microalbuminuria with acute physiology scores after 24 hours. Crit Care Med 2003, 31(1):98-103.
6. Marx G. Fluid therapy in sepsis with capillary leakage. Eur J Anaesthesiol 2003, 20:429-442.
7. Ravage Z.B., Gomez H.F., Czermak B.J., et al. Mediators of microvascular injury in dermal burn wounds. Inflammation 1998, 22:619-629.
8. Infanger M., Schmidt O., Kossmehl P., et al. Vascular endothelial growth factor serum level is strongly enhanced after burn injury and correlated with local and general tissue edema. Burns 2004, 30:305-311.
9. Clarkson B., Thompson D., Horwith M., et al. Cyclical edema and shock due to increased capillary permeability. Am J Med 1960, 29:193-216.
10. Gousseff M., Arnaud L., Lambert M., et al. The systemic capillary leak syndrome: a case series of 28 patients from a European registry. Ann Intern Med 2011, 154:464-471.
11. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definitions conference. Crit Care Med 2006, 32:421-427.
12. Fishel R.S., Are C., Barbul A. Vessel injury and capillary leak. Crit Care Med 2003, 31(8):S502-S511.
13. Seghaye M.C., Grabitz R.G., Duchateau J., et al. Inflammatory reaction and capillary leak syndrome related to cardiopulmonary bypass in neonates undergoing cardiac operations. J Thorac Cardiovasc Surg 1996, 112:687-697.
14. Nurnberger W., Michelmann I., Petrik K., et al. Activity of C1 esterase inhibitor in patients with vascular leak syndrome after bone marrow transplantation. Ann Hematol 1993, 67:17-21.
15. Pallister I., Gosling P., Alpar K., et al. Prediction of post traumatic adult respiratory distress syndrome by albumin excretion eight hours after admission. J Trauma 1997, 42:1056-1061.
16. Smith C.T., Gosling P., Sanghera K., et al. Microproteinuria predicts the severity of systemic effects of reperfusion injury following infra renal aortic aneurysm surgery. Ann Vasc Surg 1994, 8:1-5.
17. Pallister I., Dent C., Wise C.C., et al. Early post-traumatic acute respiratory distress syndrome and albumin excretion rate: a prospective evaluation of a 'point-of-care' predictive test. Injury 2001, 32:177-181.
18. Aman J., van der Heijden M., van Lingen A., et al. Plasma protein levels are markers of pulmonary vascular permeability and degree of lung injury in critically ill patients with or at risk for acute lung injury/acute respiratory distress syndrome. Crit Care Med 2011, 39(1):89-97.
19. Starling E. On the absorption of fluids from the connective tissue spaces. J Physiol 1896, 19:312-326.
20. Michel C.C. Starling: the formulation of his hypothesis of microvascular fluid exchange and its significance after 100 years. Exp Physiol 1997, 82:1-30.
21. Michel C.C., Curry F.E. Microvascular permeability. Physiol Rev 1999, 79:703-761.
22. Lenz A., Franklin G.A., Cheadle W.G. Systemic inflammation after trauma. Injury 2007, 38:1336-1345.
23. Keel M., Trentz O. Pathophysiology of polytrauma. Injury 2005, 36:691-709.
24. Heirholzer C., Billiar T.R. Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg 2001, 386:302-308.
25. Herzum I., Renz I. Inflammatory markers in SIRS, sepsis and septic shock. Curr Med Chem 2008, 15:581-587.
26. Faist E., Wichmann M.W. Immunology in the severely injured. Chirurg 1997, 68:1066-1070.
27. Moore F.A., Moore E.E. Evolving concepts in the pathogenesis of post injury multiple organ failure. Surg Clin North Am 1995, 75:257-277.
28. Polk H.C., George C.D., Wellhausen S.R., et al. A systematic study of host defense processes in badly injured patients. Ann Surg 1986, 204:282-299.
29. Gustot T. Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Curr Opin Crit Care 2011, 17:153-159.
30. Mackey D., McFall A.J. MAMPs and MIMPs: proposed classifications for inducers of innate immunity. Mol Microbiol 2006, 61:1365-1371.
31. Gill R., Ruan X., Menzel C.L., et al. Systemic inflammation and liver injury following hemorrhagic shock and peripheral tissue trauma involve functional TLR9 signaling on bone marrow-derived cells and parenchymal cells. Shock 2011, 35(2):164-170.
32. Miller A.C., Rashis R.M., Elamin E.M. The T in trauma: the helper T-cell response and the role of immunomodulation in trauma and burn patients. J Trauma 2007, 63:1407-1417.
33. Mollen K.P., Anand R.J., Tsung A., et al. Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock 2006, 26(5):430-437.
34. Nedrebø T., Berg A., Reed R.K. Effect of tumor necrosis factor-alpha, IL-beta, and IL-6 on interstitial fluid pressure in rat skin. Am J Physiol 1999, 277:H1857-H1862.
35. Hynes R.O. Integrins: versatility, modulation and signaling in cell adhesion. Cell 1992, 69:11-25.
36. Tingström A., Heldin C., Rubin K. Regulation of fibroblast mediated collagen gel contraction by platelet derived growth factor, interleukin-1α and transforming growth factor-1. J Cell Sci 1992, 102:315-322.
37. Nootcboom A., vander Linden C.J., Hendriks T. Tumor necrosis factor-α and interleukin-1β mediate endothelial permeability induced by lipopolysaccharide-stimulated whole blood. Crit Care Med 2002, 30:2063-2068.
38. Matsuda N., Hattori Y. Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction. J Smooth Muscle Res 2007, 43(4):117-137.
39. Goldblum S.E., Ding X., Campbell-Washington J. TNF-α induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction. Am J Physiol 1993, 264:C894-C905.
40. Ferro T., Neumann P., Gertzberg N., et al. Protein kinase C-α mediates endothelial barrier dysfunction induced by TNF-α. Am J Physiol 2000, 278:L1107-L1117.
41. Carey P.D., Wakefield C.H., Guilbu P.J. Neutrophil activation, vascular leak toxicity, and cytolysis during interleukin-2 infusion in human cancer. Surgery 1997, 122:918-926.
42. Lentsch A.B., Miller F.N., Edwards M.J. Mechanisms of leukocyte-mediated tissue injury induced by interleukin-2. Cancer Immunol Immunother 1999, 47:243-248.
43. Orucevic A., Lala P.K. Role of nitric oxide in IL-2 therapy-induced capillary leak syndrome. Cancer Metastasis Rev 1986, 17:127-142.
44. Samlowski W.E., Kondapanemi M., Tharkar S., et al. Endothelial nitric oxide synthase is a key mediator of interleukin-2-induced hypotension and vascular leak syndrome. J Immunother 2011, 34(5):419-427.
45. Hugli T.E. Biochemistry and biology of anaphylatoxins. Complement 1986, 3:111-127.
46. Radke A., Mottaghy K., Goldmann C., et al. C1 inhibitor prevents capillary leakage after thermal trauma. Crit Care Med 2000, 28:3224-3232.
47. Rockey D.C., Chung J.J. Regulation of inducible nitric oxide synthase in hepatic sinusoidal endothelial cells. Am J Physiol 1996, 271:G260-G267.
48. Higaki A., Ninomiya H., Sjai M., et al. Protective effect of neurotropin against lipopolysaccharide-induced hypotension and lethality linked to suppression of inducible nitric oxide synthase induction. Jpn J Pharmacol 2001, 86:329-335.
49. Piagnerelli M., Boudjeltia K.Z., Brochee D., et al. Alterations of red blood cell shape and sialic acid membrane content in septic patients. Crit Care Med 2003, 31:2156-2162.
50. De Backer D., Creteur J., Preiser J.C., et al. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002, 166:98-104.
51. Brealey D., Brand M., Hargreaves I., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002, 360:219-223.
52. Gustot T., Durand F., Lebrec D., et al. Severe sepsis in cirrhosis. Hepatology 2009, 50:2022-2033.
53. Advanced trauma life support for doctors 1997, American College of Surgeons, Chicago. 8th edition.
54. Kreimeier U. Pathophysiology of fluid imbalance. Crit Care 2000, 4(Suppl 2):S3-S7.
55. Santry H.P., Alam H.B. Fluid resuscitation: past, present, and the future. Shock 2010, 33(3):229-241.
56. Cotton B.A., Guy J.S., Morris J.A., et al. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock 2006, 26(2):115-121.
57. Alam H.B., Sun L., Ruff P., et al. E- and P- selectin expression depends on the resuscitation fluid used in hemorrhaged rats. J Surg Res 2000, 94:145-152.
58. Deb S., Martin B., Sun L., et al. Resuscitation with lactated Ringer's solution in rats with hemorrhagic shock induces immediate apoptosis. J Trauma 1999, 46:582-588.
59. Deb S., Sun L., Martin B., et al. Lactated Ringer's solution and hetastarch but not plasma resuscitation after rat hemorrhagic shock is associated with immediate lung apoptosis by the up-regulation of the bax protein. J Trauma 2000, 49:47-53.
60. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 2008, 36:296-327. [published correction appears in Crit Care Med 2008; 36:1394-1396].
61. Wilmore D.W. Metabolic response to severe surgical illness: overview. World J Surg 2000, 24:705-711.
62. Blackburn G.L. Metabolic considerations in management of surgical patients. Surg Clin North Am 2011, 91:467-480.
63. Plank L.D., Hill G.L. Sequential metabolic changes following induction of systemic inflammatory response in patients with severe sepsis or major blunt trauma. World J Surg 2000, 24:630-638.
64. Shaw J.H.F., Wolfe R.R. An integrated analysis of glucose, fat, and protein metabolism in severely traumatized patients. Studies in the basal state and the response to total parenteral nutrition. Ann Surg 1989, 209:63-72.
65. McClave S.A., Martindale R.G., Vanek V.W., et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (ASPEN). JPEN J Parenter Enteral Nutr 2009, 33:277-316.
66. Wilmore D.W., Goodwin C.W., Aulick L.H., et al. Effect of injury and infection on visceral metabolism and circulation. Ann Surg 1980, 192:491.
67. Rezende-Neto J.B., Moore E.E., Melo de Andrade M.V., et al. Systematic inflammatory response secondary to abdominal compartment syndrome: stage for multiple organ failure. J Trauma 2002, 53:1121-1128.
68. Stein D.M., Lindell A., Murdock K.R., et al. Relationship of serum and CSF biomarkers to intracranial hypertension and cerebral hypoperfusion following severe traumatic brain injury. J Trauma 2011, 70(5):1096-1103.
69. Lu J., Goh S.J., Tng P.Y., et al. Systemic inflammatory response following acute traumatic brain injury. Front Biosci 2009, 14:3795-3813.
70. Sears B.W., Volkmer D., Yong S., et al. Correlation of measurable serum markers of inflammation with lung levels following bilateral femur fracture in a rat model. J Inflamm Res 2010, 3:105-114.
71. Pape H.C., Griensven M.V., Hildebrand F.F., et al. Systemic inflammatory response after extremity or truncal fracture operations. J Trauma 2008, 65(6):1379-1384.
72. Kobbe P., Vodovotz Y., Kaczorowski D.J., et al. The role of fracture-associated soft tissue injury in the induction of systemic inflammation and remote organ dysfunction after bilateral femur fracture. J Orthop Trauma 2008, 22(6):385-390.
73. Aucar J.A., Hirshberg A. Damage control for vascular injuries. Surg Clin North Am 1997, 77(4):853-862.
74. Pourmoghadam K.K., Fogler R.J., Shaftan G.W. Ligation: an alternative for control of exsanguination in major vascular injuries. J Trauma 1997, 43:126-130.
75. Pappas P.J., Haser P.B., Teehan E.P., et al. Outcome of complex venous reconstructions in patients with trauma. J Vasc Surg 1997, 25(2):398-404.
76. Malbrain M.L., Cheatham M.L., Kirkpatrick, et al. Results from the international conference on experts on intra-abdominal compartment syndrome. I. Definitions. Intensive Care Med 2006, 32:1722-1732.
77. Rizoli S., Mamtani A., Scarpelini S. Abdominal compartment syndrome in trauma resuscitation. Curr Opin Anaesthesiol 2010, 23:251-257.
78. Raeburn C.D., Moore E.E., Biffl W.L., et al. The abdominal compartment syndrome is a morbid complication of post-injury damage control surgery. Am J Surg 2001, 182:542-546.
79. Balogh Z., McKinley B.A., Cancour C.S., et al. Secondary abdominal compartment syndrome is an elusive early complication of traumatic shock resuscitation. Am J Surg 2002, 184:538-542.
80. Demling R.H. The pathogenesis of respiratory failure after trauma and sepsis. Surg Clin North Am 1980, 60:1373-1390.
81. Layon J., Dincan D., Gallagher T.J., et al. Hypertonic saline as a resuscitation solution in hemorrhagic shock: effects on extra vascular lung water and cardiopulmonary function. Anesth Analg 1987, 66:154-158.
82. Rackow E.C., Weil M.H., Macneil A.R., et al. Effects of crystalloid and colloid fluids on extravascular lung water in hypoproteinemic dogs. J Appl Physiol 1987, 62:2421-2425.
83. Bhatia M., Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004, 202:145-146.
84. Meyrick B. Pathology of the adult respiratory distress syndrome. Crit Care Clin 1986, 2:405-425.
85. Rocco T.R., Reinert S.E., Cioffi W., et al. A 9 year, single-institution, retrospective review of death rate and prognostic factors in adult respiratory distress syndrome. Ann Surg 2001, 233(3):414-422.
86. Martin M., Salim A., Murray J., et al. The decreasing incidence and mortality of acute respiratory distress syndrome after injury: a 5-year observational study. J Trauma 2005, 59(5):1107-1113.
87. Kennedy C.S., Moffatt M. Acute traumatic brain injury in children: exploring the cutting edge in understanding, therapy, and research. Clin Pediatr Emerg Med 2004, 5(4):224-238.
88. Vos P.E., Lamers K.J.B., Hendriks J.C.M., et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004, 62(8):1303-1310.
89. Maier B., Lehnert M., Laurer H.L., et al. Delayed elevation of soluble tumor necrosis factor receptors P75 and P55 in cerebrospinal fluid and plasma after traumatic brain injury. Shock 2006, 26:122-127.
90. Scalea T.M., Bochicchio G.V., Habashi N., et al. Increased intra-abdominal, intrathoracic, and intracranial pressure after severe brain injury: multiple compartment syndrome. J Trauma 2007, 62:647-656.
91. Miller J.D., Sweet R.C., Narayan R., et al. Early insults to the injured brain. JAMA 1978, 240:439-442.
92. Signorini D.F., Andrews P.J., Jones P.A., et al. Adding insult to injury: the prognostic value of early secondary insults to survival after traumatic brain injury. J Neurol Neurosurg Psychiatry 1999, 66:26-31.
93. Chambers I.R., Treadwell L., Mendelow A.D. The cause and incidence of secondary insults in severely head-injured adults and children. Br J Neurosurg 2000, 14:424-431.
94. Zeigler E.J., Fisher C.J., Sprung C.L., et al. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against andotoxin: a randomized double blind, placebo-controlled trial. The HA-1A sepsis study group. N Engl J Med 1991, 324:429-436.
95. Abraham E., Wunderink R., Silverman H., et al. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. JAMA 1995, 273:934-941.
96. Cohen J., Cartlet J. INTERSEPT: an international, multicenter, placebo controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. Crit Care Med 1996, 24:1431-1440.
97. Abraham E., Angueto A., Guiterrez G., et al. Double blind randomized controlled trial of monoclonal antibody to human tumor necrosis factor in treatment of septic shock. Lancet 1998, 351:929-933.
98. Opal S.M., Fisher C.J., Dhainaut J.F., et al. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III randomized double-blind, placebo-controlled, multicenter trial. Crit Care Med 1997, 25:1115-1124.
99. Dhainaut J.F., Tenaillon A., Le T.Y., et al. Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. Crit Care Med 1994, 22:1720-1728.
100. Dhainaut J.F., Tenaillon A., Hemmer M. Confirming phase III clinical trial to study the efficacy of a PAF antagonist, BN 52021, in reducing mortality in patients with severe gram-negative sepsis. Am J Respir Crit Care Med 1995, 151:A447.
101. Cronin L., Cook D.J., Carlet J. Corticosteroids treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 1995, 23:1430-1439.
102. Lefering R., Neuberger E.A. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995, 23:1294-1303.
103. Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699-709.
104. Shoemaker W.C., Appel P.L., Kram H.B., et al. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988, 94:1176-1186.
105. Ronco J.J., Phang P.T., Walley K.R., et al. Oxygen consumption is independent of changes in oxygen delivery in severe adult respiratory syndrome. Am Rev Respir Dis 1993, 143:25-31.
106. Shaz B.H., Dente C.J., MacLeod J.B., et al. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion 2010, 50:493-500.
107. Beekley A.C. Damage control resuscitation: a sensible approach to the exsanguinating surgical patient. Crit Care Med 2008, 36(7):S267-S274.
108. Cai B., Dietch E.A., Grande D., et al. Anti-inflammatory resuscitation improves survival in hemorrhage with trauma. J Trauma 2009, 66:1632-1640.
109. Cannon W., Fraser J., Cowell E. The preventative treatment of wound shock. JAMA 1918, 70:618.
110. Shaftan G.W., Chiu C.J., Dennis C., et al. Fundamentals of physiologic control of arterial hemorrhage. Surgery 1965, 58:851-856.
111. Bickell W.H., Wall N.J., Pepe P.E., et al. Immediate versus delayed fluid resuscitation for hypotensive patients with torso injuries. N Engl J Med 1994, 331:1105-1109.
112. Hambly P.R., Dutton R.P. Excess mortality associated with the use of a rapid infusion system at a level 1 trauma center. Resuscitation 1996, 31:127-133.
113. Dutton R.P., Mackenzie C.F., Scalea T.M. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma 2002, 56:1141-1146.
114. Borgman M.A., Spinella P.C., Perkins J.G., et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007, 63:805-813.
115. Holcomb J.B., Hess J.R. Early massive trauma transfusion: state of the art. J Trauma 2006, 60:S1-S2.
116. Zink K.A., Sambisavin C.N., Holcomb J.B., et al. A high ratio of plasma and platelets to packed red blood cells in the first 6h of massive transfusion improves outcomes in a large multicenter study. Am J Surg 2009, 197:565-570.
117. Holcomb J.B., Wade C.E., Michalek J.E., et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008, 248:447-458.
118. Rivers E., Nguyen B., Havstad, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
119. Otero R.M., Nguyen H.B., Huang D.T., et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest 2006, 130:1579-1595.
120. Johansson P.I., Stissing T., Bochsen L., et al. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med 2009, 17:45.
121. Schöchl H., Nienaber U., Hofer G., et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010, 14(2):R55.
122. Leemann H., Lustenberger T., Talving P., et al. The role of rotation thromboelastometry in early prediction of massive transfusion. J Trauma 2010, 69(6):1403-1408.
123. Schöchl H., Cotton B., Inaba K., et al. FIBTEM provides early prediction of massive transfusion in trauma. Crit Care 2011, 15(6):R265.
124. Johansson P.I., Stensballe J. Effect of haemostatic control resuscitation on mortality in massively bleeding patients: a before and after study. Vox Sang 2009, 96:111-118.
125. Afshari A., Wikkelso A., Brok J., et al. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011, 3. CD007871.